NANOSTRUCTURED LINKED HYALURONIC ACID, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF AS EYE DROPS
The present invention relates to a method for the production of a cross-linked hyaluronic acid with BDDE (1,4-butanediol diglycidyl ether), to be used in the ophthalmic field, which, unlike what is known, is filterable, and therefore sterilizable, at 0.2 microns. La présente invention concerne un pr...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
17.12.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to a method for the production of a cross-linked hyaluronic acid with BDDE (1,4-butanediol diglycidyl ether), to be used in the ophthalmic field, which, unlike what is known, is filterable, and therefore sterilizable, at 0.2 microns.
La présente invention concerne un procédé de production d'un acide hyaluronique réticulé avec du BDDE (éther diglycidylique de 1,4-butanediol), à utiliser dans le domaine ophtalmique, qui, contrairement à ce qui est connu, est filtrable, et par conséquent stérilisable, à 0,2 micron. |
---|---|
Bibliography: | Application Number: WO2020IB55408 |